The C. elegans model in toxicity testing

Journal of Applied Toxicology

Volumn 37, Issue 1, 2017, Pages 50-59

  Hunt, Piper Reid ^a  

^a Center for Veterinary Medicine   (United States)

Author keywords

alternative model; good C. elegans culture practice; predictive toxicology; screening; toxin ranking

Indexed keywords

CAENORHABDITIS ELEGANS; CELL CULTURE; GOOD CAENORHABDITIS ELEGANS CULTURE PRACTICE; GOOD LABORATORY PRACTICE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TOXICITY ASSAY; TOXICITY TESTING; TOXICOLOGY; ANIMAL; ANIMAL TESTING ALTERNATIVE; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; LD50; PROCEDURES;

ANIMAL USE ALTERNATIVES; ANIMALS; CAENORHABDITIS ELEGANS; LETHAL DOSE 50; TOXICITY TESTS;

EID: 84992700506     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3357     Document Type: Review

References (91)

1. Alexander AG, Marfil V, Li C. 2014. Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases. Front. Genet. 5: 279.
2. Allard P, Kleinstreuer NC, Knudsen TB, Colaiacovo MP. 2013. A C. elegans screening platform for the rapid assessment of chemical disruption of germline function. Environ. Health Perspect. 121: 717–724.
3. Anderson GL, Cole RD, Williams PL. 2004. Assessing behavioral toxicity with Caenorhabditis elegans. Environ. Toxicol. Chem. 23: 1235–1240.
4. Arczewska KD, Tomazella GG, Lindvall JM, Kassahun H, Maglioni S, Torgovnick A, Henriksson J, Matilainen O, Marquis BJ, Nelson BC, Jaruga P, Babaie E, Holmberg CI, Burglin TR, Ventura N, Thiede B, Nilsen H. 2013. Active transcriptomic and proteomic reprogramming in the C. elegans nucleotide excision repair mutant xpa-1. Nucleic Acids Res. 41: 5368–5381.
5. Bargmann CI. 1998. Neurobiology of the Caenorhabditis elegans genome. Science 282: 2028–2033.
6. Bergin IL, Wilding LA, Morishita M, Walacavage K, Ault AP, Axson JL, Stark DI, Hashway SA, Capracotta SS, Leroueil PR, Maynard AD, Philbert MA. 2016. Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model. Nanotoxicology 10: 352–360.
7. Beron C, Vidal-Gadea AG, Cohn J, Parikh A, Hwang G, Pierce-Shimomura JT. 2015. The burrowing behavior of the nematode Caenorhabditis elegans: a new assay for the study of neuromuscular disorders. Genes Brain Behav. 14: 357–368.
8. Bhattacharya S, Zhang Q, Carmichael PL, Boekelheide K, Andersen ME. 2011. Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways. PLoS One 6: e20887.
9. Blumberg PM. 1988. Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res. 48: 1–8.
10. Boyd WA, McBride SJ, Freedman JH. 2007. Effects of genetic mutations and chemical exposures on Caenorhabditis elegans feeding: evaluation of a novel, high-throughput screening assay. PLoS One 2: e1259.
11. Boyd WA, McBride SJ, Rice JR, Snyder DW, Freedman JH. 2010. A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assay. Toxicol. Appl. Pharmacol. 245: 153–159.
12. Boyd WA, Smith MV, Co CA, Pirone JR, Rice JR, Shockley KR, Freedman JH. 2016. Developmental Effects of the ToxCast™ Phase I and II chemicals in Caenorhabditis elegans and corresponding responses in zebrafish, rats, and rabbits. Environ. Health Perspect. 124: 586–593.
13. Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics 77: 71–94.
14. C. elegans Sequencing Consortium. 1998. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282: 2012–2018.
15. Campbell EM, Fares H. 2010. Roles of CUP-5, the Caenorhabditis elegans orthologue of human TRPML1, in lysosome and gut granule biogenesis. BMC Cell Biol. 11: 40.
16. Casey W, Jacobs A, Maull E, Matheson J, Clarke C, Lowit A. 2015. A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). J. Am. Assoc. Lab. Anim. Sci. 54: 170–173.
17. Chauhan VM, Orsi G, Brown A, Pritchard DI, Aylott JW. 2013. Mapping the pharyngeal and intestinal pH of Caenorhabditis elegans and real-time luminal pH oscillations using extended dynamic range pH-sensitive nanosensors. ACS Nano 7: 5577–5587.
18. Chen CC, Schweinsberg PJ, Vashist S, Mareiniss DP, Lambie EJ, Grant BD. 2006. RAB-10 is required for endocytic recycling in the Caenorhabditis elegans intestine. Mol. Biol. Cell 17: 1286–1297.
19. Clokey GV, Jacobson LA. 1986. The autofluorescent "lipofuscin granules" in the intestinal cells of Caenorhabditis elegans are secondary lysosomes. Mech. Ageing Dev. 35: 79–94.
20. Cole RD, Anderson GL, Williams PL. 2004. The nematode Caenorhabditis elegans as a model of organophosphate-induced mammalian neurotoxicity. Toxicol. Appl. Pharmacol. 194: 248–256.
21. Corsi AK, Wightman B, Chalfie M. 2015. A Transparent Window into Biology: A Primer on Caenorhabditis elegans. WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/wormbook.1.177.1, http://www.wormbook.org (accessed March 2, 2016).
22. Daniels GM, Amara SG. 1999. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274: 35794–35801.
23. de Voer G, Peters D, Taschner PE. 2008. Caenorhabditis elegans as a model for lysosomal storage disorders. Biochim. Biophys. Acta 1782: 433–446.
24. Dhawan R, Dusenbery DB, Williams PL. 1999. Comparison of lethality, reproduction, and behavior as toxicological endpoints in the nematode Caenorhabditis elegans. J. Toxicol. Environ. Health A 58: 451–462.
25. Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ. 2007. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol. Sci. 95: 5–12.
26. Ellis HM, Horvitz HR. 1986. Genetic control of programmed cell death in the nematode C. elegans. Cell 44: 817–829.
27. Feng Z, Li W, Ward A, Piggott BJ, Larkspur ER, Sternberg PW, Xu XZ. 2006. A C. elegans model of nicotine-dependent behavior: regulation by TRP-family channels. Cell 127: 621–633.
28. Ferguson M, Boyer M, Sprando R. 2010. A method for ranking compounds based on their relative toxicity using neural networking, C. elegans, axenic liquid culture, and the COPAS parameters TOF and EXT. Open Access Bioinformatics 2010: 139–144.
29. Fontana L, Partridge L, Longo VD. 2010. Extending healthy life span--from yeast to humans. Science 328: 321–326.
30. Gartner A, Boag PR, Blackwell TK. 2008. Germline Survival and Apoptosis. WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/wormbook.1.145.1, http://www.wormbook.org (accessed May 16, 2016).
31. Gerstbrein B, Stamatas G, Kollias N, Driscoll M. 2005. In vivo spectrofluorimetry reveals endogenous biomarkers that report healthspan and dietary restriction in Caenorhabditis elegans. Aging Cell 4: 127–137.
32. Hall DH, Altun ZF. 2008. C. elegans Atlas. Cold Spring Harbor Laboratory Press: Cold Spring Harbor.
33. Hall SE, Beverly M, Russ C, Nusbaum C, Sengupta P. 2010. A cellular memory of developmental history generates phenotypic diversity in C. elegans. Curr. Biol. 20: 149–155.
34. Harlow PH, Perry SJ, Widdison S, Daniels S, Bondo E, Lamberth C, Currie RA, Flemming AJ. 2016. The nematode Caenorhabditis elegans as a tool to predict chemical activity on mammalian development and identify mechanisms influencing toxicological outcome. Sci. Rep. 6: 22965.
35. Hartung T. 2009. Toxicology for the twenty-first century. Nature 460: 208–212.
36. Hartung T, Balls M, Bardouille C, Blanck O, Coecke S, Gstraunthaler G, Lewis D. 2002. Good Cell Culture Practice. ECVAM Good Cell Culture Practice Task Force Report 1. Altern. Lab. Anim. 30: 407–414.
37. Hartung T, Luechtefeld T, Maertens A, Kleensang A. 2013. Integrated testing strategies for safety assessments. ALTEX 30: 3–18.
38. Hersh BM, Hartwieg E, Horvitz HR. 2002. The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types. Proc. Natl. Acad. Sci. U. S. A. 99: 4355–4360.
39. Hunt PR, Keltner Z, Gao X, Oldenburg SJ, Bushana P, Olejnik N, Sprando RL. 2014. Bioactivity of nanosilver in Caenorhabditis elegans: Effects of size, coat, and shape. Toxic. Rep. 1: 923–944.
40. Hunt PR, Marquis BJ, Tyner KM, Conklin S, Olejnik N, Nelson BC, Sprando RL. 2013. Nanosilver suppresses growth and induces oxidative damage to DNA in Caenorhabditis elegans. J. Appl. Toxicol. 33: 1131–1142.
41. Hunt PR, Olejnik N, Sprando RL. 2012. Toxicity ranking of heavy metals with screening method using adult Caenorhabditis elegans and propidium iodide replicates toxicity ranking in rat. Food Chem. Toxicol. 50: 3280–3290.
42. Jobson MA, Jordan JM, Sandrof MA, Hibshman JD, Lennox AL, Baugh LR. 2015. Transgenerational Effects of Early Life Starvation on Growth, Reproduction, and Stress Resistance in Caenorhabditis elegans. Genetics 201: 201–212.
43. Judson R, Richard A, Dix DJ, Houck K, Martin M, Kavlock R, Dellarco V, Henry T, Holderman T, Sayre P, Tan S, Carpenter T, Smith E. 2009. The toxicity data landscape for environmental chemicals. Environ. Health Perspect. 117: 685–695.
44. Kaletta T, Hengartner MO. 2006. Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5: 387–398.
45. Kenyon C. 2011. QnAs with Cynthia Kenyon. Proc. Natl. Acad. Sci. U. S. A. 108: 16875.
46. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. 1993. A C. elegans mutant that lives twice as long as wild type. Nature 366: 461–464.
47. Kim HM, Colaiacovo MP. 2014. ZTF-8 interacts with the 9-1-1 complex and is required for DNA damage response and double-strand break repair in the C. elegans germline. PLoS Genet. 10: e1004723.
48. Kim K-T, Truong L, Wehmas L, Tanguay RL. 2013. Silver nanoparticle toxicity in the embryonic zebrafish is governed by particle dispersion and ionic environment. Nanotechnology 24: 1–8.
49. Kirkland D, Aardema M, Henderson L, Muller L. 2005. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res. 584: 1–256.
50. Knight AW, Little S, Houck K, Dix D, Judson R, Richard A, McCarroll N, Akerman G, Yang C, Birrell L, Walmsley RM. 2009. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals. Regul. Toxicol. Pharmacol. 55: 188–199.
51. Krewski D, Andersen ME, Mantus E, Zeise L. 2009. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal. 29: 474–479.
52. Kuwabara PE, O'Neil N. 2001. The use of functional genomics in C. elegans for studying human development and disease. J. Inherit. Metab. Dis. 24: 127–138.
53. Lakshmanan U, Yap A, Fulwood J, Yichun L, Hoon SS, Lim J, Ting A, Sem XH, Kreisberg JF, Tan P, Tan G, Flotow H. 2014. Establishment of a novel whole animal HTS technology platform for melioidosis drug discovery. Comb. Chem. High Throughput Screen 17: 790–803.
54. Lee SJ, Murphy CT, Kenyon C. 2009. Glucose shortens the life span of C. elegans by downregulating DAF-16/FOXO activity and aquaporin gene expression. Cell Metab. 10: 379–391.
55. Leung MCK, Williams PL, Benedetto A, Au C, Helmcke KJ, Aschner M, Meyer JN. 2008. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol. Sci. 106: 5–28.
56. Levitan D, Greenwald I. 1995. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377: 351–354.
57. Li AP, Lu C, Brent JA, Pham C, Fackett A, Ruegg CE, Silber PM. 1999. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug–drug interaction potential. Chem. Biol. Interact. 121: 17–35.
58. Li Y, Gao S, Jing H, Qi L, Ning J, Tan Z, Yang K, Zhao C, Ma L, Li G. 2013. Correlation of chemical acute toxicity between the nematode and the rodent. Toxicol. Res. 2: 403–412.
59. Lu T, Aron L, Zullo J, Pan Y, Kim H, Chen Y, Yang TH, Kim HM, Drake D, Liu XS, Bennett DA, Colaiacovo MP, Yankner BA. 2014. REST and stress resistance in ageing and Alzheimer's disease. Nature 507: 448–454.
60. Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin MJ, Schwab M, Pollak M, Zhang Y, Yu Y, Becker KG, Bohr VA, Ingram DK, Sinclair DA, Wolf NS, Spindler SR, Bernier M, de Cabo R. 2013. Metformin improves healthspan and lifespan in mice. Nat. Commun. 4: 2192.
61. Middendorf PJ, Dusenbery DB. 1993. Fluoroacetic Acid Is a Potent and Specific Inhibitor of Reproduction in the Nematode Caenorhabditis elegans. J. Nematol. 25: 573–577.
62. Miranda JP, Leite SB, Muller-Vieira U, Rodrigues A, Carrondo MJ, Alves PM. 2009. Towards an extended functional hepatocyte in vitro culture. Tissue Eng. Part C Methods 15: 157–167.
63. Miwa J, Tabuse Y, Furusawa M, Yamasaki H. 1982. Tumor promoters specifically and reversibly disturb development and behavior of Caenorhabditis elegans. J. Cancer Res. Clin. Oncol. 104: 81–87.
64. Moy TI, Conery AL, Larkins-Ford J, Wu G, Mazitschek R, Casadei G, Lewis K, Carpenter AE, Ausubel FM. 2009. High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem. Biol. 4: 527–533.
65. Nakae J, Biggs WH, 3rd, Kitamura T, Cavenee WK, Wright CV, Arden KC, Accili D. 2002. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32: 245–253.
66. Nass R, Hamza I. 2007. The nematode C. elegans as an animal model to explore toxicology in vivo: solid and axenic growth culture conditions and compound exposure parameters. Curr. Protoc. Toxicol. Chapter 1: Unit1 9 doi: 10.1002/0471140856.tx0109s31.
67. NTP. 2015. West Virginia Chemical Spill: NTP Studies and Results. National Toxicology Program. http://ntp.niehs.nih.gov/results/areas/wvspill/studies/index.html [accessed 4 June 2015].
68. O'Rourke EJ, Soukas AA, Carr CE, Ruvkun G. 2009. C. elegans major fats are stored in vesicles distinct from lysosome-related organelles. Cell Metab. 10: 430–435.
69. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G. 1997. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389: 994–999.
70. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A. 2000. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. 32: 56–67.
71. Onken B, Driscoll M. 2010. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One 5: e8758.
72. Peterson RT, Nass R, Boyd WA, Freedman JH, Dong K, Narahashi T. 2008. Use of non-mammalian alternative models for neurotoxicological study. Neurotoxicology 29: 546–555.
73. Pfuhler S, Kirst A, Aardema M, Banduhn N, Goebel C, Araki D, Costabel-Farkas M, Dufour E, Fautz R, Harvey J, Hewitt NJ, Hibatallah J, Carmichael P, Macfarlane M, Reisinger K, Rowland J, Schellauf F, Schepky A, Scheel J. 2010. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis. Regul. Toxicol. Pharmacol. 57: 315–324.
74. Roh HC, Collier S, Guthrie J, Robertson JD, Kornfeld K. 2012. Lysosome-related organelles in intestinal cells are a zinc storage site in C. elegans. Cell Metab. 15: 88–99.
75. Rubin GM, Yandell MD, Wortman JR, Gabor Miklos GL, Nelson CR, Hariharan IK, Fortini ME, Li PW, Apweiler R, Fleischmann W, Cherry JM, Henikoff S, Skupski MP, Misra S, Ashburner M, Birney E, Boguski MS, Brody T, Brokstein P, Celniker SE, Chervitz SA, Coates D, Cravchik A, Gabrielian A, Galle RF, Gelbart WM, George RA, Goldstein LS, Gong F, Guan P, Harris NL, Hay BA, Hoskins RA, Li J, Li Z, Hynes RO, Jones SJ, Kuehl PM, Lemaitre B, Littleton JT, Morrison DK, Mungall C, O'Farrell PH, Pickeral OK, Shue C, Vosshall LB, Zhang J, Zhao Q, Zheng XH, Lewis S. 2000. Comparative genomics of the eukaryotes. Science 287: 2204–2215.
76. Scott CW, Peters MF, Dragan YP. 2013. Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. Toxicol. Lett. 219: 49–58.
77. Selin C, Stietz MS, Blanchard JE, Gehrke SS, Bernard S, Hall DG, Brown ED, Cardona ST. 2015. A Pipeline for Screening Small Molecules with Growth Inhibitory Activity against Burkholderia cenocepacia. PLoS One 10: e0128587.
78. Sonnhammer EL, Durbin R. 1997. Analysis of protein domain families in Caenorhabditis elegans. Genomics 46: 200–216.
79. Stergiou L, Hengartner MO. 2004. Death and more: DNA damage response pathways in the nematode C. elegans. Cell Death Differ. 11: 21–28.
80. Stutz K, Kaech A, Aebi M, Kunzler M, Hengartner MO. 2015. Disruption of the C. elegans Intestinal Brush Border by the Fungal Lectin CCL2 Phenocopies Dietary Lectin Toxicity in Mammals. PLoS One 10: e0129381.
81. Sullivan-Brown JL, Tandon P, Bird KE, Dickinson DJ, Tintori SC, Heppert JK, Meserve JH, Trogden KP, Orlowski SK, Conlon FL, Goldstein B. 2016. Identifying Regulators of Morphogenesis Common to Vertebrate Neural Tube Closure and Caenorhabditis elegans Gastrulation. Genetics 202: 123–139.
82. Tabuse Y, Miwa J. 1983. A gene involved in action of tumor promoters is identified and mapped in Caenorhabditis elegans. Carcinogenesis 4: 783–786.
83. Tabuse Y, Nishiwaki K, Miwa J. 1989. Mutations in a protein kinase C homolog confer phorbol ester resistance on Caenorhabditis elegans. Science 243: 1713–1716.
84. Tice RR, Austin CP, Kavlock RJ, Bucher JR. 2013. Improving the human hazard characterization of chemicals: a Tox21 update. Environ. Health Perspect. 121: 756–765.
85. Tralau T, Riebeling C, Pirow R, Oelgeschlager M, Seiler A, Liebsch M, Luch A. 2012. Wind of change challenges toxicological regulators. Environ. Health Perspect. 120: 1489–1494.
86. Vaux DL, Weissman IL, Kim SK. 1992. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258: 1955–1957.
87. Vidal-Gadea A, Topper S, Young L, Crisp A, Kressin L, Elbel E, Maples T, Brauner M, Erbguth K, Axelrod A, Gottschalk A, Siegel D, Pierce-Shimomura JT. 2011. Caenorhabditis elegans selects distinct crawling and swimming gaits via dopamine and serotonin. Proc. Natl. Acad. Sci. U. S. A. 108: 17504–17509.
88. White JG, Southgate E, Thomson JN, Brenner S. 1986. The Structure of the Nervous System of the Nematode Caenorhabditis elegans (the Mind of a Worm). Philos. Trans. R. Soc. Lond. B Biol. Sci. 314: 1–340.
89. Williams PL, Dusenbery DB. 1988. Using the nematode Caenorhabditis elegans to predict mammalian acute lethality to metallic salts. Toxicol. Ind. Health 4: 469–478.
90. Wittenburg N, Eimer S, Lakowski B, Rohrig S, Rudolph C, Baumeister R. 2000. Presenilin is required for proper morphology and function of neurons in C. elegans. Nature 406: 306–309.
91. Zhang Y, Zou X, Ding Y, Wang H, Wu X, Liang B. 2013. Comparative genomics and functional study of lipid metabolic genes in Caenorhabditis elegans. BMC Genomics 14: 164.